Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2014
09/25/2014US20140288093 Treatment of proteinopathies
09/25/2014US20140288084 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/25/2014US20140288083 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
09/25/2014US20140288082 Bicyclic Heteroaryl Compounds
09/25/2014US20140288070 Compounds and methods for kinase modulation, and indications therefor
09/25/2014US20140288069 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
09/25/2014US20140288062 Heteroaryl compounds and methods of use thereof
09/25/2014US20140288059 Therapeutic compositions and methods
09/25/2014US20140288052 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
09/25/2014US20140288050 Modulators of opioid receptors and methods of use thereof
09/25/2014US20140288046 Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives
09/25/2014US20140288045 Covalent inhibitors of kras g12c
09/25/2014US20140288042 Inhibitors of the renal outer medullary potassium channel
09/25/2014US20140288017 Catechol diethers as potent anti-hiv agents
09/25/2014US20140287031 Enhanced treatment regimens using mtor inhibitors
09/25/2014US20140286943 Cyclopropyl modulators of p2y12 receptor
09/24/2014EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same
09/24/2014EP2781216A1 Chemokine receptor activity regulator
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/24/2014EP2780333A1 Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
09/24/2014EP2780332A1 Morpholinyl benzotriazine for use in cancer therapy
09/24/2014EP2780303A1 Separation technique, photo-oxidation of organic substrates, and photo catalysts
09/23/2014US8841453 Hybrid cholinesterase inhibitors
09/23/2014US8841448 Fluoroergoline analogs
09/23/2014US8841446 Medicaments containing vardenafil hydrochloride trihydrate
09/23/2014US8841443 Silafluorene metalloporphyrin-benzene organic semiconductor material and preparing method and uses thereof
09/23/2014US8841318 Substituted heterocycles as janus kinase inhibitors
09/23/2014US8841306 Antimicrobials
09/23/2014US8841299 Substituted pyrrolo[1,2-a]pyrazines as tankyrase inhibitors
09/23/2014US8841289 Heterocyclic derivatives
09/18/2014WO2014145780A1 Purification of rapamycin derivatives
09/18/2014WO2014145576A2 Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
09/18/2014WO2014144747A1 Substituted 6,5-fused bicyclic heteroaryl compounds
09/18/2014WO2014144651A2 An intelligent and configurable fluid delivery system and methods for its use
09/18/2014WO2014144592A2 Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
09/18/2014WO2014144487A1 System and method of sending pci express data over ethernet connection
09/18/2014WO2014144455A1 1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
09/18/2014WO2014144285A1 Meropenem derivatives and uses thereof
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014143915A1 Novel crystalline forms
09/18/2014WO2014143799A2 Substituted xanthines and methods of use thereof
09/18/2014WO2014143610A1 Pyrrolotriazines as potassium ion channel inhibitors
09/18/2014WO2014143607A1 Pyrrolopyridazines as potassium ion channel inhibitors
09/18/2014WO2014143606A1 Pyrrolotriazines as potassium ion channel inhibitors
09/18/2014WO2014143583A1 Imidazo pyridine compounds
09/18/2014WO2014143242A1 Compounds useful as inhibitors of atr kinase
09/18/2014WO2014143241A1 Compounds useful as inhibitors of atr kinase
09/18/2014WO2014142748A1 Quorum sensing inhibitors
09/18/2014WO2014142472A1 Compound for organic electrical element, organic electrical element using same, and electronic device thereof
09/18/2014WO2014142308A1 Bicyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
09/18/2014WO2014142307A1 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof
09/18/2014WO2014142292A1 Fused heterocyclic compound or salt thereof, agricultural and horticultural insecticide containing fused heterocyclic compound, and method for using agricultural and horticultural insecticide
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014140597A1 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromet hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors
09/18/2014WO2014140321A1 Antiviral indolo[2,3-b]quinoxaline
09/18/2014WO2014140318A1 Improved process for acyl transfer reactions
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014WO2014140065A1 N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals
09/18/2014WO2014139983A1 [1,2,4]triazolo[4,3-a]quinoxalines as dual pde2/pde10 inhibitors
09/18/2014WO2014139978A1 New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
09/18/2014WO2014139970A1 Processes and intermediates for preparing a medicament
09/18/2014WO2014139572A1 Process for making anagrelide
09/18/2014WO2014139489A1 Method for the preparation of ticagrelor and intermediates suitable therefore
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014WO2014139388A1 Novel indole derivatives useful as anti-diabetic agents
09/18/2014WO2014139328A1 Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
09/18/2014WO2014139326A1 Pyrazolo compounds and uses thereof
09/18/2014WO2014138772A1 A crystalline form of an anxiolytic compound
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275131 Organic compounds
09/18/2014US20140275126 Processes and intermediates for preparing a medicament
09/18/2014US20140275125 Inhibitors of bruton's tyrosine kinase
09/18/2014US20140275119 Compounds and compositions for the treatment of parasitic diseases
09/18/2014US20140275097 NOVEL CHIRAL N-ACYL-5,6,7(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
09/18/2014US20140275096 P2x7 modulators
09/18/2014US20140275092 Pyrazolo compounds and uses thereof
09/18/2014US20140275090 Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
09/18/2014US20140275088 Small molecule malarial aldolase-trap enhancers and glideosome inhibitors
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275067 Transient Protection of Normal Cells During Chemotherapy
09/18/2014US20140275065 Substituted 7-azabicyles and their use as orexin receptor modulators
09/18/2014US20140275061 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/18/2014US20140275033 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
09/18/2014US20140275031 Piperidin-4-yl azetidine derivatives as jak1 inhibitors
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275021 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275020 Inhibitors of the renal outer medullary potassium channel
09/18/2014US20140275014 Heteroaromatic compounds as btk inhibitors
09/18/2014US20140275012 Heteroaromatic compounds as btk inhibitors
09/18/2014US20140275010 Quaternary salts
09/18/2014US20140275009 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275004 Pyrrolopyrimindine cdk9 kinase inhibitors
09/18/2014US20140274980 Compound
09/18/2014US20140274907 Pyrrolobenzodiazepines
09/18/2014US20140274896 Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
09/18/2014US20140271922 Pirenzepine as an agent in cancer treatment
09/18/2014US20140271734 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
09/18/2014US20140271466 HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 573